Wheel-running exercise in laboratory rodents (animal model useful to study the neurobiology 36 of aerobic exercise) decreases behavioral markers of vulnerability to addictive properties of 37 various drugs of abuse including cocaine. However, neurobiological mechanisms underpinning 38 this protective effect are far from being fully characterized and understood. Here, 28-day-old 39 female C57BL/6J mice were housed with (n=48) or without (n=48) a running wheel for 6 weeks 40 before being tested for acute locomotor responsiveness and initiation of locomotor sensitization 41 to intraperitoneal injections of 8 mg/kg cocaine. The long-term expression of sensitization took 42 place 3 weeks after the last session. On the day after, all mice underwent a microPET imaging 43 session with [ 18 F]fallypride radiotracer (dopamine 2/3 receptor (D2/3R) antagonist). Exercised 44 mice were less sensitive to acute and sensitized cocaine hyperlocomotor effects, such 45 attenuation being particularly well-marked for long-term expression of sensitization (η²p = 46 0.262). Additionally, we found that chronic administrations of cocaine was associated with a 47 clear-cut increase of [ 18 F]fallypride binding potential in mouse striatum (η²p = 0.170), 48 presumably reflecting an increase in postsynaptic D2/3R density in this region. Finally, we 49 found evidence that wheel-running exercise was associated with a moderate decrease in D2/3R 50 density in striatum (η²p = 0.075), a mechanism that might contribute to protective properties of 51 such form of exercise against drugs of abuse vulnerability. 52 53 54 55 KEY WORDS 56 Wheel-running; exercise; cocaine sensitization; mice; dopamine; microPET 57 58 59 60 61 62 63 64 65 66 67 68 69 By the end of the 90's, society's perspective on addiction changed, promoted in a certain extent 70 by a new pathophysiological vision of addictive disorders, dubbed as the Brain Model Disease 71
diurnal (light on) wheel-running activity of mice randomly assigned to exercise conditions. Since at this 169 stage of the experiment mice from the cocaine (COC, n=24) and saline (SAL, n=24) groups were still 170 undistinguishable, no inferential statistics were conducted on these data. All mice showed a rapid 171 increase in wheel-running over the two first weeks until reaching a plateau. Bars represent 95% 172 confidence intervals. 173 174 Drug Treatments 175 (−)-Cocaine hydrochloride (BELGOPIA, Louvain-La-Neuve, Belgium), dissolved in an 176 isotonic saline solution (0.9% NaCl), was injected intraperitoneally at a dose of 8 mg/kg in a 177 volume of 0.01 ml/g of body weight, the control treatment consisting of an equal volume of 178 isotonic saline solution. The dose and route of administration were selected on the basis of our 179 previous studies 41,42 , these parameters being known to also induce rewarding-like effects in 180 mice as measured by conditioned place preference 46 . 181 182 Behavioral Test Chambers 183 A battery of eight chambers, connected to a custom written software for data collection, was 184 used to measure mice locomotor activity, one mouse being tested in each chamber. Each activity 185 chamber was constituted of a removable transparent polycarbonate tub (22 x 12 cm surface x 186 12 cm height), embedded onto a black-paint wooden plank serving as a stable base. The lid was 187 made of a transparent perforated acryl-glass tablet. Two photocell sources and detectors were 188 mounted on the plank such that infrared light-beams were located on the two long sides of the 189 tub at 2-cm heights from the floor, 8-cm apart and spaced 6.5 cm from each end of the tub. 190 Locomotor activity was measured in terms of crossings detected by the beams, one crossing Compounds, Radeberg, Germany). After the labelling reaction that was conducted in 202 acetonitrile (1 mL) with 3.5 mg of the substrate at 120 °C for 5 min, the crude reaction mixture 203 was diluted with water (6 mL) and the resulting solution injected on a semi-preparative HPLC 204 column. The purification was carried out at 254 nm using a Phenomenex Luna C18 column (5 205 μm, 250 × 15 mm) at a flow rate of 7 mL/min with an isocratic eluent of 206 water/acetonitrile/trietylamine (45:55:0.1%; retention time of 22 min). The subsequent 207 formulation step 48 was realized by passing the HPLC collection solution, previously diluted 208 with sodium chloride 0.9% (30 mL) and sodium ascorbate (30 mg) through a tC18 cartridge 209 (360 mg, Waters). [ 18 F]fallypride was then eluted from the support with ethanol (1 mL) and 210 diluted with an isotonic solution (6 mL) containing sodium ascorbate (10 mg) as stabilizer. 211 Based on the starting activity recovered from the cyclotron (111 GBq), this process afforded 212 batches of [ 18 F]fallypride ready for subsequent dilution for animal injection. The radiochemical 213 yield was of 32 ± 5% (mean ± SD, decay corrected; n=24). At the end of beam, the averaged 214 specific activity was 49 ± 20.4 Ci/µmol (1813.6 ± 755.6 GBq/µmol, decay corrected, n=24) and 215 the synthesis duration of about 50 min. All the process was automated on a FASTlab synthesizer 216 from GE Healthcare with single use components. Twenty-four [ 18 F]fallypride microPET imaging sessions were completed and all necessary 220 efforts were made to systematically repeat the same procedure. Anesthesia was induced with 221 4% of isoflurane, afterward the mice were placed prone in a dedicated bed. Anesthesia was 222 maintained with 1-2% isoflurane in a mixture of air and oxygen (30%) at 0.6 l/min. A physiological monitoring system (Minerve, Esternay, France). Temperature was maintained at 226 37 ± 0.5° C, using an air warming system. Due to practical reasons, the whole experiment was organized into twelve lots purchased and 292 tested successively (each lot consisting of 8 mice). In each lot, two mice were assigned to one of the four experimental group by means of a computer-generated randomization schedule, the 294 eight mice housed in acclimation cages contributing to theses four possible groups 295 (sedentary/cocaine, sedentary/saline, exercised/cocaine, and exercised/saline). Therefore, the 296 four groups were systematically represented within each lot by 2 mice to take into account any 297 between-lot variability as well as that due to time and circumstances of testing (i.e. randomized 298 block design, Supp.2). Additionally, due to impracticality to test 8 mice in a row on the same 299 micro-PET scanning session, each block (n=8) was further split into 2 blocks (n=4) for the test 300 for expression of sensitization and microPET imaging procedures. Again, the four groups were 301 systematically represented within each block by one mouse (Supp.2). Therefore, mice were 302 tested for expression of sensitization either 21 (half) or 23 (other half) days after the last cocaine 303 injection, while all mice underwent neuroimaging scan 24h after this test. Note that the order 304 of neuroimaging session was counterbalanced across subjects to avoid potential bias due to the the spatial resolution of the microPET scanner, which is about 1.5 mm 2 in our setup (i.e.
535
Siemens Focus 120) 49 . This has of course to be taken into account when attempting to achieve 536 in vivo molecular imaging of mouse brain. The mouse brain atlas implemented in Pmod 3.7, 537 derived from the work of Mirrione and coll., didn't allow to analyze separately the ventral and 538 the dorsal parts of the striatum, the Accumbens nucleus (Acb) and the Caute-Putamen (CPu) 539 respectively 51 interpreted the data and substantially revised the work.
